- Home
- TGB vs KOD Comparison
TGB vs KOD Comparison
Compare TGB & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TGB | KOD |
|---|---|---|
| Founded | 1966 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2002 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TGB | KOD |
|---|---|---|
| Price | $6.76 | $38.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $5.00 | ★ $35.43 |
| AVG Volume (30 Days) | ★ 5.0M | 1.6M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $67.93 | N/A |
| Revenue Next Year | $24.16 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.67 | $1.92 |
| 52 Week High | $9.25 | $45.60 |
Technical Indicators
Market Signals| Indicator | TGB | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 64.44 |
| Support Level | $5.36 | $21.82 |
| Resistance Level | $9.08 | $45.60 |
| Average True Range (ATR) | 0.35 | 3.61 |
| MACD | 0.11 | 1.72 |
| Stochastic Oscillator | 89.86 | 73.03 |
Price Performance
Historical ComparisonAbout TGB Taseko Mines Ltd.
Taseko Mines Ltd is a copper-focused mining company engaged in acquiring, developing, and operating large tonnage mineral deposits in stable jurisdictions that are capable of supporting a mine. Its principal assets are the wholly-owned Gibraltar mine (Gibraltar), which is located in central British Columbia (BC), and the Florence Copper mine, located in Arizona. Taseko also owns the Yellowhead copper, New Prosperity copper-gold, and Aley niobium projects in British Columbia, Canada.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.